Drug intelligence / Profile preview

68Ga-CAIX-targeted polypeptide molecular probe

Development stage: Unknown
Lead developer: Harbin Medical University Cancer Hospital
Modality: Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Peptides
Administration: Intravenous

Overview

68Ga-CAIX-targeted polypeptide molecular probe is a diagnostic radiopharmaceutical developed by Harbin Medical University Cancer Hospital for the detection of early metastasis in urinary tract tumors, including kidney cancer. The probe consists of a polypeptide ligand that specifically targets Carbonic Anhydrase IX (CAIX), a transmembrane protein that is constitutively overexpressed in clear cell renal cell carcinoma (ccRCC) and other hypoxic tumors. By labeling this polypeptide with the positron-emitting isotope Gallium-68 (68Ga), the probe enables high-sensitivity PET-CT imaging to visualize CAIX-positive lesions and assess biodistribution and radiation dosimetry in patients.

Other names: 68Ga-CAIX-targeted polypeptideCAIX-targeted 68Ga polypeptide molecular probeCAIX-targeted68Ga polypeptide molecular probeCAIX-targeted-68Ga polypeptide molecular probe68Ga-labeled CAIX-targeted polypeptide

Targets

CA9 (Carbonic anhydrase IX)

Beyond the preview

Go deeper on 68Ga-CAIX-targeted polypeptide molecular probe.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 68Ga-CAIX-targeted polypeptide molecular probe.

Explore the full profile